What will the prevailing sentiment be about Rapamycin as a longevity drug in 2028?
11
10kṀ10122028
9%
Wonder-drug: Most adults should consider it
20%
Valuable but imperfect: Some healthy adults should consider it, but there are major drawbacks
26%
Unproven but promising: Too early to tell
33%
Ineffective: Any benefits are too small to be worth the drawbacks
12%
Harmful/scandalous: Clear serious drawbacks that last beyond cessation of treatment
I'll post a proposed resolution here for discussion at least one week before resolving. May resolve to a mixture of up to two different choices in borderline cases.
If there's any substantial disagreement, I'll ask a popular LLM-style chatbot to select a resolution based on the title of the market, the choices, and the text of the ten first Google News results for "rapamycin for longevity".
Esta pergunta Ă© gerenciada e resolvida pela Predita.
Get 
1,000 to start trading!
1,000Pessoas também estão operando
Perguntas relacionadas
What percent of those taking rapamycin to slow aging will comment a positive or neutral review?
56% chance
Will Stephen Wolfram self-report or get in the news 4 any pro-longevity intervention (eg rapamycin/ozempic) by EOY 2028?
26% chance
Will Peter Thiel start regularly taking rapamycin by EOY 2027?
35% chance
Will jurgen schmidhuber end up taking rapamycin by EOY 2028
41% chance
Will Jose Luis ricon finally start regularly taking rapamycin by 2030?
45% chance
Will a study performed by the Dog Aging Project show a statistically significant effect of rapamycin on lifespan extension between control groups and a treatment group?
73% chance
Will a senolytic drug be used clinically to slow, prevent, or reverse aging by the end of 2033?
46% chance
Will any sitting senator out themselves as taking rapamycin by EOY 2030?
24% chance
Will a human-proven cure for aging that increases life expectancy by at least 20 years exist by 2036?
20% chance
Will there be a cheaper form of fatty15 (https://www.rapamycin.news/t/c15-0-fatty-acid/14804/27) by EOY2026?
50% chance